Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05232656 · ClinicalTrials.gov registry record · NA

PREventing Adverse Events Post-Discharge Through Proactive Identification, Multidisciplinary Communication, and Technology

A NA study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
268
Enrollment target

NCT05232656 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 268 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05232656, a NA study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
268 participants
Enrollment target

Study Summary

The goal of this study is to expand the use of previously developed patient safety dashboards and patient-centered discharge checklists to three general medicine units in an affiliated community hospital. The safety dashboard and interactive pre-discharge checklist are cognitive aids for clinicians and patients, respectively, that serve to facilitate early detection of patients at risk for preventable harm, including suboptimal discharge preparation. The aims of this study are to: 1. Enhance the safety dashboard and interactive pre-discharge checklist to include "smart" notifications for hospital-based clinicians when patients are at high risk for adverse events or have identified specific concerns related to discharge based on their checklist responses. 2. Expand intervention to general medical units at our community hospital-affiliate, BWFH. 3. Evaluate impact on post-discharge AEs for patients discharged from BWFH who are at risk for preventable harm and hospital readmission.

Interventions

  • BEHAVIORAL Pre-Discharge Checklist and Patient Safety Dashboard

Trial Details

FieldValue
Enrollment Target 268 participants
Start Date 2018-09-01
Est. Completion 2020-09-30
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT05232656

The ClinicalTrials.gov registry entry for NCT05232656 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Pre-Discharge Checklist and Patient Safety Dashboard is the first listed.

NCT05232656 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05232656 about?

NCT05232656 is a clinical study titled "PREventing Adverse Events Post-Discharge Through Proactive Identification, Multidisciplinary Communication, and Technology". The goal of this study is to expand the use of previously developed patient safety dashboards and patient-centered discharge checklists to three general medicine units in an affiliated community hospital. The safety dashboard and interactive pre-discharge checklist are cognitive aids for clinicians ...

What is the current status of trial NCT05232656?

This trial is currently completed. It is a NA study. The enrollment target is 268 participants. The study started on 2018-09-01. Estimated completion is 2020-09-30.

What interventions are being tested in trial NCT05232656?

The interventions under investigation include: Pre-Discharge Checklist and Patient Safety Dashboard (BEHAVIORAL).

Who is sponsoring clinical trial NCT05232656?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.